Journal of Andrology Cross-Journal Searching
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cohen, D. R.
Right arrow Articles by Brackett, N. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cohen, D. R.
Right arrow Articles by Brackett, N. L.
Journal of Andrology, Vol. 25, No. 6, November/December 2004
Copyright © American Society of Andrology

Sperm Motility in Men With Spinal Cord Injuries Is Enhanced by Inactivating Cytokines in the Seminal Plasma

DANIEL R. COHEN, SARMISTHA BASU, JOSH M. RANDALL, TEODORO C. ABALLA, CHARLES M. LYNNE AND NANCY L. BRACKETT

From the Miami Project to Cure Paralysis and the Department of Urology, University of Miami School of Medicine, Miami, Florida.

Correspondence to: Dr Nancy L. Brackett, The Miami Project to Cure Paralysis, University of Miami School of Medicine, PO Box 016960, Mail Code R-48, Miami, FL 33101 (e-mail: NBrackett{at}miami.edu).


The goal of this study was to determine whether inactivating specific cytokines in seminal plasma improves sperm motility in men affected by spinal cord injury (SCI). For this purpose, we used monoclonal antibodies to interleukin 6 (IL6), interleukin 1 beta (IL1-ß), and tumor necrosis factor alpha (TNF-{alpha}), all 3 cytokines having been previously detected at high concentrations in the seminal plasma of patients with SCI. In a group of 17 SCI men with low sperm motility (mean ± SE, 20.1% ± 3.1%), treatment with the 3 monoclonal antibodies at the median neutralization dose concentrations for 1.0 to 1.5 hours improved sperm motility in all cases. Effectiveness was higher in those specimens with a pretreatment sperm motility between 11% and 30% (from 19.3% ± 1.4% to 41.9% ± 4.9%, P < .0002), suggesting that pretreatment sperm motility might represent an indicator of cell damage and, therefore, a factor that influences monoclonal antibody effectiveness. To the best of our knowledge, these results represent the first rational treatment for improving low sperm motility in these severely affected patients.

     Key words: Infertility, ejaculation, semen, IL1-ß, IL6, TNF-{alpha}




This article has been cited by other articles:


Home page
Hum ReprodHome page
V. Tronchon, F. Vialard, M. El Sirkasi, H. Dechaud, J. Rollet, M. Albert, M. Bailly, P. Roy, C. Mauduit, P. Fenichel, et al.
Tumor necrosis factor-alpha -308 polymorphism in infertile men with altered sperm production or motility
Hum. Reprod., December 1, 2008; 23(12): 2858 - 2866.
[Abstract] [Full Text] [PDF]


Home page
J AndrolHome page
N. L. Brackett, D. R. Cohen, E. Ibrahim, T. C. Aballa, and C. M. Lynne
Neutralization of Cytokine Activity at the Receptor Level Improves Sperm Motility in Men With Spinal Cord Injuries
J Androl, September 1, 2007; 28(5): 717 - 721.
[Abstract] [Full Text] [PDF]


Home page
J AndrolHome page
J. Zhu, N. L. Brackett, T. C. Aballa, C. M. Lynne, M. A. Witt, H. I. Kort, and W. E. Roudebush
High Seminal Platelet-Activating Factor Acetylhydrolase Activity in Men With Spinal Cord Injury
J Androl, May 1, 2006; 27(3): 429 - 433.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 by The American Society of Andrology.